Clinical trial · Interventional
Polaris Oncology Survivor Transition (POST) System
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The POST's public health impact is likely to be substantial because it will improve cancer survivorship planning, which is currently an important deficiency in cancer care recognized by the Institute of Medicine and the American College of Surgeons. The POST may have many potential benefits for patients such as: 1. improved long-term health outcomes; 2. improved psychosocial outcomes and quality of life; 3. smoother transitions back into old and new life roles; and 4. improved continuity and coordination of care between providers. Most importantly, the POST's influence may reach beyond the patients it directly serves as it could help scientists and health care providers understand the potential benefits of cancer survivorship planning and how to best design and implement survivorship planning when patients are ending treatment for cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| POST Intervention | Behavioral | — | UNRESOLVED |
| POST Treatment as Usual | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- POST SCP
- description
- Patient receives Survivorship Care Plan (SCP) after active treatment ends. It will be discussed with the patient. SCP includes medical and psychosocial history, medical contact information, 5-year follow-up plan and educational materials.
- interventionNames
- Behavioral: POST Intervention
- type
- ACTIVE_COMPARATOR
- label
- POST TAU
- description
- Patient receives treatment as usual (TAU) after active treatment ends.
- interventionNames
- Behavioral: POST Treatment as Usual
Primary outcomes (1)
- measure
- Changes in Quality of Life
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * 18 years or older * Confirmed diagnosis of breast cancer (not metastatic) * A final active treatment appointment scheduled with oncology team * Able to read or understand English at a 6th grade level Exclusion Criteria: * Altered mental status (e.g., psychosis, delirium, disorientation) * Visual problems preventing them from reading the assessment and reports * Severe illness that would preclude conversation or interface with a computer (e.g.,persistent nausea/vomiting, severe pain) * Unable to read or understand English at a 6th grade level * Characteristics that would prevent adequate follow-up (e.g., lack of a telephone)
References
Publications (1)
- DERIVEDO'Hea EL, Creamer S, Flahive JM, Keating BA, Crocker CR, Williamson SR, Edmiston KL, Harralson T, Boudreaux ED. Survivorship care planning, quality of life, and confidence to transition to survivorship: A randomized controlled trial with women ending treatment for breast cancer. J Psychosoc Oncol. 2022;40(5):574-594. doi: 10.1080/07347332.2021.1936336. Epub 2021 Jun 20. PMID 34151734